JP2015500862A5 - - Google Patents

Download PDF

Info

Publication number
JP2015500862A5
JP2015500862A5 JP2014548012A JP2014548012A JP2015500862A5 JP 2015500862 A5 JP2015500862 A5 JP 2015500862A5 JP 2014548012 A JP2014548012 A JP 2014548012A JP 2014548012 A JP2014548012 A JP 2014548012A JP 2015500862 A5 JP2015500862 A5 JP 2015500862A5
Authority
JP
Japan
Prior art keywords
methyl
amino
pyrazol
chloro
pyrrolidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2014548012A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015500862A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/076371 external-priority patent/WO2013092854A1/en
Publication of JP2015500862A publication Critical patent/JP2015500862A/ja
Publication of JP2015500862A5 publication Critical patent/JP2015500862A5/ja
Withdrawn legal-status Critical Current

Links

JP2014548012A 2011-12-23 2012-12-20 キナーゼ阻害剤としてのピリミジン−2,4−ジアミン誘導体 Withdrawn JP2015500862A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11195662.9 2011-12-23
EP11195662 2011-12-23
PCT/EP2012/076371 WO2013092854A1 (en) 2011-12-23 2012-12-20 Pyrimidine-2,4-diamine derivatives as kinase inhibitors

Publications (2)

Publication Number Publication Date
JP2015500862A JP2015500862A (ja) 2015-01-08
JP2015500862A5 true JP2015500862A5 (cg-RX-API-DMAC7.html) 2016-02-18

Family

ID=47429836

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014548012A Withdrawn JP2015500862A (ja) 2011-12-23 2012-12-20 キナーゼ阻害剤としてのピリミジン−2,4−ジアミン誘導体

Country Status (10)

Country Link
US (1) US20150005281A1 (cg-RX-API-DMAC7.html)
EP (1) EP2794598A1 (cg-RX-API-DMAC7.html)
JP (1) JP2015500862A (cg-RX-API-DMAC7.html)
KR (1) KR20140114344A (cg-RX-API-DMAC7.html)
CN (1) CN104169272A (cg-RX-API-DMAC7.html)
AU (1) AU2012357038B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014015723A8 (cg-RX-API-DMAC7.html)
CA (1) CA2860095A1 (cg-RX-API-DMAC7.html)
RU (1) RU2014130214A (cg-RX-API-DMAC7.html)
WO (1) WO2013092854A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150013554A (ko) * 2012-05-24 2015-02-05 셀좀 리미티드 Tyk2 억제제로서의 헤테로시클릴 피리미딘 유사체
AR094537A1 (es) 2013-11-07 2015-08-12 Bristol Myers Squibb Co COMPUESTOS DE PIRIDILO SUSTITUIDOS CON ALQUILAMIDA ÚTILES COMO MODULADORES DE LAS RESPUESTAS DE IL-12, IL-23 Y/O IFNa
CN105793251B (zh) * 2013-12-05 2018-10-12 豪夫迈·罗氏有限公司 具有亲电子官能性的杂芳基吡啶酮和氮杂-吡啶酮化合物
RU2016129380A (ru) * 2013-12-20 2018-01-25 СИГНАЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Замещенные диаминопиримидильные соединения, их композиции и способы лечения с их участием
US9403801B2 (en) 2014-03-28 2016-08-02 Calitor Sciences, Llc Substituted heteroaryl compounds and methods of use
US10106507B2 (en) 2014-08-03 2018-10-23 H. Lee Moffitt Cancer Center and Research Insitute, Inc. Potent dual BRD4-kinase inhibitors as cancer therapeutics
EP3347097B1 (en) 2015-09-11 2021-02-24 Sunshine Lake Pharma Co., Ltd. Substituted aminopyrimidine derivatives as modulators of the kinases jak, flt3 and aurora
US10738016B2 (en) 2015-10-13 2020-08-11 H. Lee Moffitt Cancer Center And Research Institute, Inc. BRD4-kinase inhibitors as cancer therapeutics
WO2019057112A1 (zh) * 2017-09-21 2019-03-28 北京赛特明强医药科技有限公司 2-取代吡唑氨基-4-取代氨基-5-嘧啶甲酰胺类化合物、组合物及其应用
CN113214230B (zh) * 2017-09-21 2022-10-04 北京赛特明强医药科技有限公司 2-取代吡唑氨基-4-取代氨基-5-嘧啶甲酰胺类化合物、组合物及其应用
CN110734427B (zh) * 2018-07-20 2021-01-15 北京赛特明强医药科技有限公司 含烯基的嘧啶甲酰胺类化合物、组合物及其应用
CN111718332B (zh) * 2019-03-19 2021-08-17 北京赛特明强医药科技有限公司 2-取代吡唑氨基-4-取代氨基-5-嘧啶甲酰胺类化合物、组合物及其应用
CN111004215B (zh) * 2019-12-22 2022-08-09 华北理工大学 2,4-取代嘧啶类衍生物及其制备方法和在制备抗肿瘤药物中的应用
WO2025166124A1 (en) * 2024-02-02 2025-08-07 Deciphera Pharmaceuticals, Llc Ulk inhibitors and methods of use thereof
WO2025166161A1 (en) * 2024-02-02 2025-08-07 Deciphera Pharmaceuticals, Llc Ulk inhibitors and methods of use thereof

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0961780T3 (da) 1997-02-12 2007-08-27 Electrophoretics Ltd Proteinmarkörer for lungecancer og anvendelse deraf
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
IL144745A0 (en) 1999-02-10 2002-06-30 Astrazeneca Ab Quinazoline derivatives as angiogenesis inhibitors
DE60039206D1 (de) 1999-11-05 2008-07-24 Astrazeneca Ab Neue Quinazolin-Derivate
SK287188B6 (sk) 1999-12-10 2010-02-08 Pfizer Products Inc. Pyrolo [2,3-d]pyrimidínová zlúčenina, jej použitie a farmaceutická kompozícia alebo kombinácia s jej obsahom
MXPA02008021A (es) 2000-02-15 2004-04-05 Sugen Inc Indolinonas sustituidas con pirroles inhibidoras de proteinquinasas.
US7109337B2 (en) 2002-12-20 2006-09-19 Pfizer Inc Pyrimidine derivatives for the treatment of abnormal cell growth
UA80767C2 (en) 2002-12-20 2007-10-25 Pfizer Prod Inc Pyrimidine derivatives for the treatment of abnormal cell growth
GEP20084357B (en) 2002-12-20 2008-04-29 Pfizer Prod Inc Pyrimidine derivatives for the treatment of abnormal cell growth
ITMI20022758A1 (it) 2002-12-23 2004-06-24 Isagro Ricerca Srl Nuovi uracili ad attivita' erbicida.
EP1751142A1 (en) 2004-05-14 2007-02-14 Pfizer Products Incorporated Pyrimidines derivatives for the treatment of abnormal cell growth
PL1891446T3 (pl) 2005-06-14 2013-08-30 Cellzome Gmbh Sposób identyfikacji nowych związków oddziałujących z enzymami
JP4332590B2 (ja) 2005-12-21 2009-09-16 ファイザー・プロダクツ・インク 異常細胞増殖を治療するためのピリミジン誘導体
GB0605691D0 (en) 2006-03-21 2006-05-03 Novartis Ag Organic Compounds
ATE417274T1 (de) 2006-06-01 2008-12-15 Cellzome Ag Verfahren zur identifizierung von mit zap-70 wechselwirkenden molekülen und zur zap-70- reinigung
EP2054392A2 (en) * 2006-06-15 2009-05-06 Boehringer Ingelheim International GmbH 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha
JP2009544592A (ja) 2006-07-21 2009-12-17 ノバルティス アクチエンゲゼルシャフト Jakキナーゼ阻害剤としての2,4−ジ(アリールアミノ)−ピリミジン−5−カルボキサミド化合物
WO2008060301A1 (en) 2006-11-16 2008-05-22 Pharmacopeia , Llc 7-substituted purine derivatives for immunosuppression
DE102007010801A1 (de) * 2007-03-02 2008-09-04 Bayer Cropscience Ag Diaminopyrimidine als Fungizide
US7947698B2 (en) 2007-03-23 2011-05-24 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the JAK pathway
US7834024B2 (en) 2007-03-26 2010-11-16 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the JAK pathway
JP4782239B2 (ja) 2007-04-18 2011-09-28 ファイザー・プロダクツ・インク 異常細胞増殖治療のためのスルホニルアミド誘導体
US20090274698A1 (en) 2007-07-06 2009-11-05 Shripad Bhagwat Combination anti-cancer therapy
CA2960692C (en) 2008-04-16 2019-09-24 Portola Pharmaceuticals, Inc. 2,6-diamino-pyrimidin-5-yl-carboxamides as syk or jak kinase inhibitors
EA201100435A1 (ru) * 2008-09-03 2011-10-31 Байер Кропсайенс Аг Тиениламинопиримидины в качестве фунгицидов
CL2009001884A1 (es) 2008-10-02 2010-05-14 Incyte Holdings Corp Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
WO2010083207A2 (en) 2009-01-15 2010-07-22 Rigel Pharmaceuticals, Inc. Protein kinase c inhibitors and uses thereof
EP2419423A1 (en) 2009-04-14 2012-02-22 Cellzome Limited Fluoro substituted pyrimidine compounds as jak3 inhibitors
AR076550A1 (es) * 2009-05-06 2011-06-22 Portola Pharm Inc Inhibidores de la janus tirosina kinasa (jak)
WO2010146133A1 (en) * 2009-06-18 2010-12-23 Cellzome Limited Heterocyclylaminopyrimidines as kinase inhibitors
CA2771675A1 (en) 2009-09-11 2011-03-17 Cellzome Limited Ortho substituted pyrimidine compounds as jak inhibitors
TW201125867A (en) 2009-10-20 2011-08-01 Cellzome Ltd Heterocyclyl pyrazolopyrimidine analogues as JAK inhibitors
MX2012012328A (es) 2010-04-30 2013-05-06 Cellzome Ltd Compuestos pirazol como inhibidores de jak.
US20130143915A1 (en) 2010-07-01 2013-06-06 Cellzome Limited Triazolopyridines as tyk2 inhibitors
WO2012022681A2 (en) 2010-08-20 2012-02-23 Cellzome Limited Heterocyclyl pyrazolopyrimidine analogues as selective jak inhibitors
WO2012062704A1 (en) 2010-11-09 2012-05-18 Cellzome Limited Pyridine compounds and aza analogues thereof as tyk2 inhibitors

Similar Documents

Publication Publication Date Title
JP2015500862A5 (cg-RX-API-DMAC7.html)
RU2014130214A (ru) Пиримидин-2, 4-диаминовые производные в качестве ингибиторов киназы
JP2014521623A5 (cg-RX-API-DMAC7.html)
CA2671744A1 (en) Compounds and compositions as protein kinase inhibitors
SI3074386T1 (en) New aminopyrimidine derivatives
JP2020023529A5 (cg-RX-API-DMAC7.html)
JP2017510555A5 (cg-RX-API-DMAC7.html)
JP2020073561A5 (cg-RX-API-DMAC7.html)
RU2433128C2 (ru) Новые пиримидиновые производные и их применение в терапии, а также применение пиримидиновых производных в изготовлении лекарственного средства для предупреждения и/или лечения болезни альцгеймера
JP2017530999A5 (cg-RX-API-DMAC7.html)
JP2017510554A5 (cg-RX-API-DMAC7.html)
HRP20231310T1 (hr) Heteroarilaminopirimidin amidni inhibitori autofagije i postupci njihove primjene
RU2386630C2 (ru) Соединения и композиции в качестве ингибиторов протеинтирозинкиназы
RU2014152257A (ru) Гетероциклильные пиримидиновые аналоги в качестве ингибиторов tyk2
JP2017506659A5 (cg-RX-API-DMAC7.html)
RU2013155456A (ru) Соединения пирролидинилмочевины и пирролидинилтиомочевины как ингибиторы киназы trka
HRP20110882T1 (hr) Ciklopenta [d] pirimidini kao inhibitori kinaze akt proteina
JP2014526549A5 (cg-RX-API-DMAC7.html)
JP2013510876A5 (cg-RX-API-DMAC7.html)
AU2010286569A1 (en) Compounds and compositions as protein kinase inhibitors
RU2016136116A (ru) Фармацевтические соединения
HRP20172006T1 (hr) Derivati pirazol-aminopiridina kao lrrk2-modulatori
JP2009513575A5 (cg-RX-API-DMAC7.html)
PE20060501A1 (es) Compuestos de aminoheteroarilo enantiomericamente puros como inhibidores de proteina quinasa
RU2015121374A (ru) Ингибиторы alk-киназы